EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Therapeutic drug monitoring of imipramine correlation with a case study

Mohammed Misbah Ul Haq, Bachi Tazneem

INNOSC Theranostics and Pharmacological Sciences · 2023

DOI: 10.36922/itps.0505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INNOSC Theranostics and Pharmacological Sciences, 2023. Verfasst von Mohammed Misbah Ul Haq und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article provides an overview of the pharmacokinetics, pharmacodynamics, contraindications, and precautions of imipramine, a tricyclic antidepressant (TCA) medication commonly used to treat depression and other mental health conditions. Imipramine’s pharmacokinetic properties include rapid absorption, distribution to various tissues, metabolism in the liver, and elimination through the kidneys. Imipramine’s pharmacodynamic effects are mediated through its actions on various neurotransmitters, including serotonin, norepinephrine, and dopamine. The article also discusses the contraindications and precautions associated with imipramine use. Imipramine is contraindicated in patients with a history of hypersensitivity to TCAs, recent myocardial infarction, and certain cardiac disorders. It should also be used with caution in patients with a history of seizures, urinary retention, glaucoma, and liver or kidney disease. In conclusion, imipramine is a medication with well-established pharmacokinetic and pharmacodynamic properties, but its use is associated with certain contraindications and precautions. Clinicians should carefully consider these factors when prescribing imipramine to patients with depression or other mental health conditions.

Zitieren

APA

Haq, M. M. U., & Tazneem, B. (2023). Therapeutic drug monitoring of imipramine correlation with a case study. INNOSC Theranostics and Pharmacological Sciences. https://doi.org/10.36922/itps.0505

Vancouver

Haq MMU, Tazneem B. Therapeutic drug monitoring of imipramine correlation with a case study. INNOSC Theranostics and Pharmacological Sciences. 2023. doi:10.36922/itps.0505

BibTeX
@article{Haq2023,
  author = {Haq, Mohammed Misbah Ul and Tazneem, Bachi},
  title = {Therapeutic drug monitoring of imipramine correlation with a case study},
  journal = {INNOSC Theranostics and Pharmacological Sciences},
  year = {2023},
  doi = {10.36922/itps.0505}
}
Kostenlos starten →